Stay updated with breaking news from Everett Cunningham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eighteen analysts that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12 month target […]
Ardevora Asset Management LLP lowered its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 28.5% during the third quarter, HoldingsChannel.com reports. The firm owned 140,253 shares of the medical research company’s stock after selling 55,847 shares during the period. Ardevora Asset Management LLP’s holdings in Exact Sciences were worth $9,568,000 at […]
Guggenheim started coverage on shares of Exact Sciences (NASDAQ:EXAS – Free Report) in a report released on Thursday morning, Marketbeat.com reports. The firm issued a buy rating and a $90.00 target price on the medical research company’s stock. Several other analysts also recently commented on EXAS. The Goldman Sachs Group decreased their price objective on […]
Guggenheim initiated coverage on shares of Exact Sciences (NASDAQ:EXAS – Free Report) in a research note released on Thursday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $90.00 target price on the medical research company’s stock. EXAS has been the subject of several other reports. Wolfe Research began coverage on shares of […]
Regal Investment Advisors LLC increased its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 32.0% in the second quarter, Holdings Channel reports. The fund owned 7,304 shares of the medical research company’s stock after purchasing an additional 1,772 shares during the quarter. Regal Investment Advisors LLC’s holdings in Exact Sciences were worth $686,000 […]